Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I testing of MB-204.
Amount Raised
C$600,000
Round Type
Grant
Investors
Description
Marvel Biosciences Corp. has secured $600,000 in funding from the Alberta Innovates CarE program for Phase I testing of its lead compound, MB-204. This funding will significantly contribute to the overall costs of the clinical trial. Alberta Innovates' program is competitive and provides third-party validation for the potential of MB-204
Quick answer
Marvel Biosciences raised C$600,000 in a Grant round, dated March 30, 2026. Investors: Alberta Innovates.
- How much did Marvel Biosciences raise?
- Marvel Biosciences raised C$600,000 in a Grant round on March 30, 2026.
- Who invested in Marvel Biosciences?
- Alberta Innovates is named as investors in this round.
- What does Marvel Biosciences do?
- Marvel Biosciences Corp., through its wholly owned subsidiary Marvel Biotechnology Inc., is a Calgary-based biotechnology company developing new treatments for neurological diseases and neurodevelopmental disorders.
- Where is Marvel Biosciences based and how big is it?
- Fundz records about 5 employees.
- Who are the decision-makers at Marvel Biosciences?
- Fundz holds 1 contact at Marvel Biosciences, including the CEO & Co-Founder. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Marvel Biosciences that raised within 45 days of this round, from Fundz verified event records.
- CREATE Medicines raised $122M (Series B) on May 14, 2026.
- Ollin Biosciences raised $330M (Series B) on May 14, 2026.
- Citius Oncology raised $37M on May 6, 2026.
- Remedium Bio raised $10M (Series A) on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Aura Biosciences, Inc. raised $238M (Post-IPO Equity) on May 4, 2026.
Who to call at Marvel Biosciences, and when
A new round usually means Marvel Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Marvel Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Marvel Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Marvel Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Marvel Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Marvel Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.